December 25, 2014 8:27 AM ET

Biotechnology

Company Overview of Asterand Bioscience, Inc.

Company Overview

Asterand Bioscience, Inc. develops technology and application solutions that provide researchers the tools to investigate and understand cellular reprogramming worldwide. It provides a set of tools for generating iPS cells, as well as cell lines, media, differentiation, rabbit anti-mouse/human, cytokines/proteins, matrices, reprogramming systems, transfection reagents, small molecules, and antibodies; and iPS cell services, training courses, and video protocols. The company serves reprogramming, self-renewal, and differentiation applications. Asterand Bioscience, Inc. was formerly known as Stemgent, Inc. and changed its name to Asterand Bioscience, Inc. in October 2014. The company was incor...

51 Moulton Street

Cambridge, MA 02138

United States

Founded in 2007

Phone:

617-245-0000

Fax:

617-494-0398

Key Executives for Asterand Bioscience, Inc.

Executive Chairman
Age: 53
Chief Financial Officer
Chief Operating Officer and Executive Vice President
Chief Commercial Officer
Vice President
Compensation as of Fiscal Year 2014.

Asterand Bioscience, Inc. Key Developments

Asterand Bioscience Seeks Acquisitions

Asterand Bioscience, Inc. (Stemgent Inc.) is seeking acquisitions. John Canepa, Chief Financial Officer of Asterand Bioscience, said, "We'll now be looking at acquisitions. We're strategizing that now. There's an opportunity to grow the business here."

Cellectis bioresearch SAS Announces Collaboration with Stemgent, Inc

Cellectis bioresearch SAS announced collaboration agreement with Stemgent Inc. to provide research services that combines mRNA reprogramming technology and genome engineering. The partnership marries Cellectis bioresearch's leadership in genome engineering with Stemgent's expertise in cellular reprogramming.

Similar Private Companies By Industry

Company Name Region
Revolution Bioengineering, LLC United States
Natural Chem Group LLC United States
Applied Veterinary Systems United States
Cytonics Corporation United States
Cadrus Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
September 8, 2014
Stemgent, Inc., Induced Pluripotent Stem Cells Business
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Asterand Bioscience, Inc., please visit www.stemgent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.